Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Generac price target lowered to $159 from $165 at Credit Suisse » 07:06
02/02/23
02/02
07:06
02/02/23
07:06
GNRC

Generac

$126.52 /

+5.99 (+4.97%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNRC Generac
$126.52 /

+5.99 (+4.97%)

GNRC Generac
$126.52 /

+5.99 (+4.97%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
GNRC Generac
$126.52 /

+5.99 (+4.97%)

GNRC Generac
$126.52 /

+5.99 (+4.97%)

GNRC Generac
$126.52 /

+5.99 (+4.97%)

GNRC Generac
$126.52 /

+5.99 (+4.97%)

Tuesday
Hot Stocks
Generac announces home standby generator integration with ecobee smart » 07:56
01/31/23
01/31
07:56
01/31/23
07:56
GNRC

Generac

$113.21 /

-4.475 (-3.80%)

Generac announced that…

Generac announced that its entire line of Wi-Fi and cellular-enabled home standby generators will soon integrate with the latest ecobee smart thermostats, creating a single energy management hub for the home. By integrating ecobee smart thermostats with Generac home standby generators, home energy management will be incorporated into a central, easy-to-use interface. Homeowners can quickly and easily see that their generator is ready to power on in a power outage. For homeowners fueling their generator with propane, they will also be able to digitally link their fuel tank, enabling them to monitor fuel levels 24/7 on the same interface.

ShowHide Related Items >><<
GNRC Generac
$113.21 /

-4.475 (-3.80%)

GNRC Generac
$113.21 /

-4.475 (-3.80%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
GNRC Generac
$113.21 /

-4.475 (-3.80%)

GNRC Generac
$113.21 /

-4.475 (-3.80%)

GNRC Generac
$113.21 /

-4.475 (-3.80%)

GNRC Generac
$113.21 /

-4.475 (-3.80%)

Hot Stocks
Generac introduces electric vehicle charging system » 07:54
01/31/23
01/31
07:54
01/31/23
07:54
GNRC

Generac

$113.21 /

-4.475 (-3.80%)

Generac announced the…

Generac announced the introduction of its first electric vehicle charging system. The Generac EV charger offers electric vehicle owners a reliable and easy-to-install home charger from one of the most respected names in residential power. The 48A / 11.5kW Generac EV charger is a Level 2 home charger capable of charging a car battery in as little as four to six hours, depending on the car battery's capacity and charge need. The unit's J1772 connector is out-of-the-box compatible with nearly all EVs on the market today, and a NEMA-4 enclosure makes the unit rated for both indoor and outdoor residential installation. The Generac EV charger is the latest in Generac's complete line of home energy solutions and will be mass marketed and available for purchase in the second half of 2023.

ShowHide Related Items >><<
GNRC Generac
$113.21 /

-4.475 (-3.80%)

GNRC Generac
$113.21 /

-4.475 (-3.80%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
GNRC Generac
$113.21 /

-4.475 (-3.80%)

GNRC Generac
$113.21 /

-4.475 (-3.80%)

GNRC Generac
$113.21 /

-4.475 (-3.80%)

GNRC Generac
$113.21 /

-4.475 (-3.80%)

Over a month ago
On The Fly
Buy/Sell: Wall Street's top 5 stock calls this week » 14:26
12/30/22
12/30
14:26
12/30/22
14:26
NFLX

Netflix

$290.30 /

-0.64 (-0.22%)

, FOUR

Shift4 Payments

$55.17 /

-1.255 (-2.22%)

, SWKH

SWK Holdings

$17.46 /

-0.63 (-3.48%)

, GNRC

Generac

$100.16 /

-0.48 (-0.48%)

, IDYA

Ideaya Biosciences

$18.08 /

-0.07 (-0.39%)

What has Wall Street been…

ShowHide Related Items >><<
SWKH SWK Holdings
$17.46 /

-0.63 (-3.48%)

NFLX Netflix
$290.30 /

-0.64 (-0.22%)

IDYA Ideaya Biosciences
$18.08 /

-0.07 (-0.39%)

GNRC Generac
$100.16 /

-0.48 (-0.48%)

FOUR Shift4 Payments
$55.17 /

-1.255 (-2.22%)

NFLX Netflix
$290.30 /

-0.64 (-0.22%)

12/29/22 CFRA
Netflix upgraded to Buy from Sell at CFRA
12/22/22 Needham
Netflix 2023 estimates cut at Needham
12/20/22 Oppenheimer
Oppenheimer reiterates bullish stance on Netflix's ad tier driving sub growth
12/19/22 Morgan Stanley
Netflix price target raised to $275 from $250 at Morgan Stanley
FOUR Shift4 Payments
$55.17 /

-1.255 (-2.22%)

12/29/22 Piper Sandler
Shift4 Payments assumed with an Overweight at Piper Sandler
11/16/22 Susquehanna
Susquehanna sees Twitter payments potential for Shift4 Payments
11/08/22 Truist
Shift4 Payments price target lowered to $55 from $65 at Truist
11/07/22 Truist
Shift4 Payments price target lowered to $55 from $65 at Truist
SWKH SWK Holdings
$17.46 /

-0.63 (-3.48%)

12/28/22 Lake Street
SWK Holdings assumed with a Buy at Lake Street
04/18/22 Lake Street
SWK Holdings initiated with a Buy at Lake Street
GNRC Generac
$100.16 /

-0.48 (-0.48%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
IDYA Ideaya Biosciences
$18.08 /

-0.07 (-0.39%)

12/28/22 Capital One
Capital One starts Ideaya Biosciences at Overweight with $29 price target
12/28/22 Capital One
Ideaya Biosciences initiated with an Overweight at Capital One
11/18/22 Baird
Ideaya Biosciences price target raised to $24 from $18 at Baird
10/27/22 Citi
Ideaya Biosciences initiated with a Buy at Citi
SWKH SWK Holdings
$17.46 /

-0.63 (-3.48%)

NFLX Netflix
$290.30 /

-0.64 (-0.22%)

IDYA Ideaya Biosciences
$18.08 /

-0.07 (-0.39%)

GNRC Generac
$100.16 /

-0.48 (-0.48%)

FOUR Shift4 Payments
$55.17 /

-1.255 (-2.22%)

  • 15
    Sep
NFLX Netflix
$290.30 /

-0.64 (-0.22%)

GNRC Generac
$100.16 /

-0.48 (-0.48%)

NFLX Netflix
$290.30 /

-0.64 (-0.22%)

IDYA Ideaya Biosciences
$18.08 /

-0.07 (-0.39%)

GNRC Generac
$100.16 /

-0.48 (-0.48%)

FOUR Shift4 Payments
$55.17 /

-1.255 (-2.22%)

NFLX Netflix
$290.30 /

-0.64 (-0.22%)

GNRC Generac
$100.16 /

-0.48 (-0.48%)

On The Fly
What You Missed On Wall Street On Wednesday » 16:32
12/28/22
12/28
16:32
12/28/22
16:32
GNRC

Generac

$96.26 /

+5.11 (+5.61%)

, TSLA

Tesla

$112.71 /

+3.66 (+3.36%)

, RIOT

Riot Blockchain

$3.29 /

-0.135 (-3.95%)

, RIVN

Rivian Automotive

$17.73 /

+0.01 (+0.06%)

, AKLI

Akili

/

+

, IDYA

Ideaya Biosciences

$17.48 /

+0.975 (+5.91%)

, GILD

Gilead

$84.56 /

-0.44 (-0.52%)

, JNCE

Jounce Therapeutics

/

+

, XOM

Exxon Mobil

$108.35 /

-1.8401 (-1.67%)

, AMZN

Amazon.com

$81.85 /

-1.22 (-1.47%)

, DIS

Disney

$84.17 /

-2.21 (-2.56%)

, MMAT

Meta Materials

$1.15 /

+0.161 (+16.36%)

, AKTS

Akoustis

$2.70 /

+0.295 (+12.27%)

, KALA

Kala Pharmaceuticals

$12.47 /

+8.57 (+219.74%)

, TLRY

Tilray

$2.58 /

-0.055 (-2.09%)

, TGTX

TG Therapeutics

$8.46 /

+0.625 (+7.98%)

, MERQ

Merqueo

/

+

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

MMAT Meta Materials
$1.15 /

+0.161 (+16.36%)

KALA Kala Pharmaceuticals
$12.47 /

+8.57 (+219.74%)

JNCE Jounce Therapeutics
/

+

IDYA Ideaya Biosciences
$17.48 /

+0.975 (+5.91%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

GILD Gilead
$84.56 /

-0.44 (-0.52%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

AKTS Akoustis
$2.70 /

+0.295 (+12.27%)

AKLI Akili
/

+

GNRC Generac
$96.26 /

+5.11 (+5.61%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
TSLA Tesla
$112.71 /

+3.66 (+3.36%)

12/28/22 Morgan Stanley
Tesla price target lowered to $250 from $330 at Morgan Stanley
12/28/22 Wedbush
Wedbush lays out what needs to happen for Tesla shares to bottom
12/28/22 Baird
Baird cuts Tesla target to $252, keeps as 'Best Idea' in 2023
12/23/22 Wedbush
Tesla price target lowered to $175 from $250 at Wedbush
RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

12/28/22 Cantor Fitzgerald
Riot, Rivian among Cantor's top technology picks for 2023
12/15/22 Northland
Riot Blockchain price target lowered to $10 from $12 at Northland
12/15/22 DA Davidson
Riot Blockchain price target lowered to $10 from $12 at DA Davidson
11/23/22 H.C. Wainwright
Riot Blockchain assumed with a Buy at H.C. Wainwright
RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

12/20/22 Cantor Fitzgerald
Rivian Automotive initiated with an Overweight at Cantor Fitzgerald
12/20/22 Mizuho
Rivian Automotive price target lowered to $50 from $58 at Mizuho
12/13/22 Canaccord
Rivian Automotive production pause preserves capital, says Canaccord
AKLI Akili
/

+

12/28/22 Morgan Stanley
Akili initiated with an Equal Weight at Morgan Stanley
11/18/22 BofA
Akili Interactive initiated with a Neutral at BofA with spending needed to scale
11/18/22 BofA
Akili Interactive initiated with a Neutral at BofA
10/25/22 Credit Suisse
Akili Interactive initiated with an Outperform at Credit Suisse
IDYA Ideaya Biosciences
$17.48 /

+0.975 (+5.91%)

12/28/22 Capital One
Capital One starts Ideaya Biosciences at Overweight with $29 price target
12/28/22 Capital One
Ideaya Biosciences initiated with an Overweight at Capital One
11/18/22 Baird
Ideaya Biosciences price target raised to $24 from $18 at Baird
10/27/22 Citi
Ideaya Biosciences initiated with a Buy at Citi
GILD Gilead
$84.56 /

-0.44 (-0.52%)

12/22/22 Piper Sandler
Gilead's Sunlenca could expand into broader HIV, says Piper Sandler
12/13/22 BofA
Gilead resumed with a Neutral at BofA
12/12/22 Needham
Arcellx price target raised to $35 from $31 at Needham
12/09/22 Piper Sandler
Gilead price target raised to $104 from $96 at Piper Sandler
JNCE Jounce Therapeutics
/

+

11/11/22 Raymond James
Raymond James downgrades Jounce to Outperform on ILT inhibitor data
11/10/22 Raymond James
Jounce Therapeutics downgraded to Outperform from Strong Buy at Raymond James
08/30/22 Piper Sandler
Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
08/05/22 H.C. Wainwright
Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

12/19/22 Piper Sandler
Exxon Mobil price target lowered to $127 from $131 at Piper Sandler
11/22/22 Citi
Exxon Mobil price target raised to $110 from $98 at Citi
11/11/22 Piper Sandler
Exxon Mobil price target raised to $131 from $113 at Piper Sandler
11/01/22 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

12/23/22 Citi
Sunday Ticket could accelerate adoption of subscriptions at YouTube, says Citi
12/19/22 Evercore ISI
Amazon.com price target lowered to $150 from $170 at Evercore ISI
12/16/22 JPMorgan
JPMorgan cuts Amazon target, says sentiment at multi-year low
12/12/22 Wells Fargo
Amazon GMV beginning to re-accelerate as softlines comps slow, says Wells Fargo
DIS Disney
$84.17 /

-2.21 (-2.56%)

12/20/22 Wells Fargo
Wells says Disney spinning ESPN/ABC 'a reasonably probable event' for late 2023
12/12/22 Morgan Stanley
Disney price target lowered to $115 from $125 at Morgan Stanley
11/30/22 Atlantic Equities
Atlantic Equities sees 'no easy fix' for Iger at Disney
11/22/22 Tigress Financial
Disney price target lowered to $177 from $229 at Tigress Financial
MMAT Meta Materials
$1.15 /

+0.161 (+16.36%)

AKTS Akoustis
$2.70 /

+0.295 (+12.27%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
KALA Kala Pharmaceuticals
$12.47 /

+8.57 (+219.74%)

11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
05/17/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $5 from $6 at H.C. Wainwright
03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
TLRY Tilray
$2.58 /

-0.055 (-2.09%)

12/28/22 Piper Sandler
Tilray estimates lowered on softer beer sales at Piper Sandler
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

12/29/22 JPMorgan
TG shares under-reflect Briumvi potential, says JPMorgan
12/29/22 H.C. Wainwright
TG Therapeutics price target raised to $24 from $19 at H.C. Wainwright
12/29/22 BofA
BofA sees 'bearish setup' for TG Therapeutics into Briumvi launch
12/28/22 Cantor Fitzgerald
Label for TG Therapeutics' Briumvi slightly better than expected, says Cantor
MERQ Merqueo
/

+

XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

KALA Kala Pharmaceuticals
$12.47 /

+8.57 (+219.74%)

JNCE Jounce Therapeutics
/

+

IDYA Ideaya Biosciences
$17.48 /

+0.975 (+5.91%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

GILD Gilead
$84.56 /

-0.44 (-0.52%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

AKTS Akoustis
$2.70 /

+0.295 (+12.27%)

AKLI Akili
/

+

  • 15
    Sep
XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

MMAT Meta Materials
$1.15 /

+0.161 (+16.36%)

JNCE Jounce Therapeutics
/

+

IDYA Ideaya Biosciences
$17.48 /

+0.975 (+5.91%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

GILD Gilead
$84.56 /

-0.44 (-0.52%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

AKTS Akoustis
$2.70 /

+0.295 (+12.27%)

XOM Exxon Mobil
$108.35 /

-1.8401 (-1.67%)

TSLA Tesla
$112.71 /

+3.66 (+3.36%)

TLRY Tilray
$2.58 /

-0.055 (-2.09%)

TGTX TG Therapeutics
$8.46 /

+0.625 (+7.98%)

RIVN Rivian Automotive
$17.73 /

+0.01 (+0.06%)

RIOT Riot Blockchain
$3.29 /

-0.135 (-3.95%)

MMAT Meta Materials
$1.15 /

+0.161 (+16.36%)

GNRC Generac
$96.26 /

+5.11 (+5.61%)

GILD Gilead
$84.56 /

-0.44 (-0.52%)

DIS Disney
$84.17 /

-2.21 (-2.56%)

AMZN Amazon.com
$81.85 /

-1.22 (-1.47%)

AKLI Akili
/

+

On The Fly
What You Missed On Wall Street This Morning » 12:02
12/28/22
12/28
12:02
12/28/22
12:02
GNRC

Generac

$95.20 /

+4.05 (+4.44%)

, TSLA

Tesla

$110.20 /

+1.15 (+1.05%)

, RIOT

Riot Blockchain

$3.31 /

-0.11 (-3.22%)

, RIVN

Rivian Automotive

$17.63 /

-0.09 (-0.51%)

, AKLI

Akili

$1.04 /

+0.03 (+2.97%)

, IDYA

Ideaya Biosciences

$17.00 /

+0.495 (+3.00%)

, GILD

Gilead

$84.63 /

-0.37 (-0.44%)

, JNCE

Jounce Therapeutics

$1.04 /

+0.3027 (+41.06%)

, XOM

Exxon Mobil

$108.44 /

-1.75 (-1.59%)

, AMZN

Amazon.com

$82.00 /

-1.07 (-1.29%)

, PFE

Pfizer

$50.90 /

-0.22 (-0.43%)

, MMAT

Meta Materials

$1.09 /

+0.101 (+10.26%)

, AKTS

Akoustis

$2.67 /

+0.26 (+10.81%)

, KALA

Kala Pharmaceuticals

$13.20 /

+9.3 (+238.46%)

, TLRY

Tilray

$2.54 /

-0.09 (-3.42%)

, AMC

AMC Entertainment

$3.93 /

-0.12 (-2.96%)

, MERQ

Merqueo

/

+

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

MMAT Meta Materials
$1.09 /

+0.101 (+10.26%)

KALA Kala Pharmaceuticals
$13.20 /

+9.3 (+238.46%)

JNCE Jounce Therapeutics
$1.04 /

+0.3027 (+41.06%)

IDYA Ideaya Biosciences
$17.00 /

+0.495 (+3.00%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

GILD Gilead
$84.63 /

-0.37 (-0.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

AKTS Akoustis
$2.67 /

+0.26 (+10.81%)

AKLI Akili
$1.04 /

+0.03 (+2.97%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
TSLA Tesla
$110.20 /

+1.15 (+1.05%)

12/28/22 Wedbush
Wedbush lays out what needs to happen for Tesla shares to bottom
12/28/22 Baird
Baird cuts Tesla target to $252, keeps as 'Best Idea' in 2023
12/23/22 Wedbush
Tesla price target lowered to $175 from $250 at Wedbush
12/22/22 Canaccord
Tesla price target lowered to $275 from $304 at Canaccord
RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

12/28/22 Cantor Fitzgerald
Riot, Rivian among Cantor's top technology picks for 2023
12/15/22 Northland
Riot Blockchain price target lowered to $10 from $12 at Northland
12/15/22 DA Davidson
Riot Blockchain price target lowered to $10 from $12 at DA Davidson
11/23/22 H.C. Wainwright
Riot Blockchain assumed with a Buy at H.C. Wainwright
RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

12/20/22 Cantor Fitzgerald
Rivian Automotive initiated with an Overweight at Cantor Fitzgerald
12/20/22 Mizuho
Rivian Automotive price target lowered to $50 from $58 at Mizuho
12/13/22 Canaccord
Rivian Automotive production pause preserves capital, says Canaccord
AKLI Akili
$1.04 /

+0.03 (+2.97%)

12/28/22 Morgan Stanley
Akili initiated with an Equal Weight at Morgan Stanley
11/18/22 BofA
Akili Interactive initiated with a Neutral at BofA with spending needed to scale
11/18/22 BofA
Akili Interactive initiated with a Neutral at BofA
10/25/22 Credit Suisse
Akili Interactive initiated with an Outperform at Credit Suisse
IDYA Ideaya Biosciences
$17.00 /

+0.495 (+3.00%)

12/28/22 Capital One
Capital One starts Ideaya Biosciences at Overweight with $29 price target
12/28/22 Capital One
Ideaya Biosciences initiated with an Overweight at Capital One
11/18/22 Baird
Ideaya Biosciences price target raised to $24 from $18 at Baird
10/27/22 Citi
Ideaya Biosciences initiated with a Buy at Citi
GILD Gilead
$84.63 /

-0.37 (-0.44%)

12/22/22 Piper Sandler
Gilead's Sunlenca could expand into broader HIV, says Piper Sandler
12/13/22 BofA
Gilead resumed with a Neutral at BofA
12/12/22 Needham
Arcellx price target raised to $35 from $31 at Needham
12/09/22 Piper Sandler
Gilead price target raised to $104 from $96 at Piper Sandler
JNCE Jounce Therapeutics
$1.04 /

+0.3027 (+41.06%)

11/11/22 Raymond James
Raymond James downgrades Jounce to Outperform on ILT inhibitor data
11/10/22 Raymond James
Jounce Therapeutics downgraded to Outperform from Strong Buy at Raymond James
08/30/22 Piper Sandler
Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
08/05/22 H.C. Wainwright
Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

12/19/22 Piper Sandler
Exxon Mobil price target lowered to $127 from $131 at Piper Sandler
11/22/22 Citi
Exxon Mobil price target raised to $110 from $98 at Citi
11/11/22 Piper Sandler
Exxon Mobil price target raised to $131 from $113 at Piper Sandler
11/01/22 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

12/23/22 Citi
Sunday Ticket could accelerate adoption of subscriptions at YouTube, says Citi
12/19/22 Evercore ISI
Amazon.com price target lowered to $150 from $170 at Evercore ISI
12/16/22 JPMorgan
JPMorgan cuts Amazon target, says sentiment at multi-year low
12/12/22 Wells Fargo
Amazon GMV beginning to re-accelerate as softlines comps slow, says Wells Fargo
PFE Pfizer
$50.90 /

-0.22 (-0.43%)

12/27/22 Cantor Fitzgerald
Roivant's upcoming data readouts could move stock higher, says Cantor Fitzgerald
12/21/22 Barclays
Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
12/15/22 Guggenheim
Vaxcyte initiated with a Buy at Guggenheim on pneumococcal vaccine potential
12/13/22 Piper Sandler
Takeda deal has positive read through for Ventyx, says Piper
MMAT Meta Materials
$1.09 /

+0.101 (+10.26%)

AKTS Akoustis
$2.67 /

+0.26 (+10.81%)

11/14/22 Oppenheimer
Akoustis price target lowered to $7 from $8 at Oppenheimer
11/14/22 Piper Sandler
Akoustis remains on track to continue expanding solutions, says Piper Sandler
09/13/22 Piper Sandler
Akoustis price target lowered to $5 from $7 at Piper Sandler
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
KALA Kala Pharmaceuticals
$13.20 /

+9.3 (+238.46%)

11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
05/17/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $5 from $6 at H.C. Wainwright
03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
TLRY Tilray
$2.54 /

-0.09 (-3.42%)

12/28/22 Piper Sandler
Tilray estimates lowered on softer beer sales at Piper Sandler
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

11/25/22 Citi
AMC Entertainment price target lowered to $1.10 from $1.20 at Citi
11/06/22 Citi
AMC Entertainment price target lowered to $1.20 from $3.13 at Citi
10/12/22 B. Riley
AMC Entertainment price target lowered to $7.50 from $11 at B. Riley
08/23/22 Wedbush
Wedbush reiterates Underperform rating on AMC Entertainment, cuts target to $2
MERQ Merqueo
/

+

XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

KALA Kala Pharmaceuticals
$13.20 /

+9.3 (+238.46%)

JNCE Jounce Therapeutics
$1.04 /

+0.3027 (+41.06%)

IDYA Ideaya Biosciences
$17.00 /

+0.495 (+3.00%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

GILD Gilead
$84.63 /

-0.37 (-0.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

AKTS Akoustis
$2.67 /

+0.26 (+10.81%)

AKLI Akili
$1.04 /

+0.03 (+2.97%)

  • 15
    Sep
XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

MMAT Meta Materials
$1.09 /

+0.101 (+10.26%)

KALA Kala Pharmaceuticals
$13.20 /

+9.3 (+238.46%)

JNCE Jounce Therapeutics
$1.04 /

+0.3027 (+41.06%)

IDYA Ideaya Biosciences
$17.00 /

+0.495 (+3.00%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

GILD Gilead
$84.63 /

-0.37 (-0.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

AKTS Akoustis
$2.67 /

+0.26 (+10.81%)

XOM Exxon Mobil
$108.44 /

-1.75 (-1.59%)

TSLA Tesla
$110.20 /

+1.15 (+1.05%)

TLRY Tilray
$2.54 /

-0.09 (-3.42%)

RIVN Rivian Automotive
$17.63 /

-0.09 (-0.51%)

RIOT Riot Blockchain
$3.31 /

-0.11 (-3.22%)

PFE Pfizer
$50.90 /

-0.22 (-0.43%)

MMAT Meta Materials
$1.09 /

+0.101 (+10.26%)

GNRC Generac
$95.20 /

+4.05 (+4.44%)

GILD Gilead
$84.63 /

-0.37 (-0.44%)

AMZN Amazon.com
$82.00 /

-1.07 (-1.29%)

AMC AMC Entertainment
$3.93 /

-0.12 (-2.96%)

AKLI Akili
$1.04 /

+0.03 (+2.97%)

Options
Early notable gainers among liquid option names on December 28th » 09:55
12/28/22
12/28
09:55
12/28/22
09:55
TSLA

Tesla

$113.52 /

+4.47 (+4.10%)

, GNRC

Generac

$95.75 /

+4.6 (+5.05%)

, TECH

Bio-Techne

$83.22 /

+1.11 (+1.35%)

, DXCM

DexCom

$110.63 /

+0.79 (+0.72%)

, NWSA

News Corp.

$18.33 /

+0.05 (+0.27%)

Notable gainers among…

Notable gainers among liquid option names this morning include Tesla (TSLA) $114.53 +5.43, Generac (GNRC) $95.22 +4.06, Bio Techne (TECH) $83.92 +1.71, DexCom (DXCM) $111.53 +1.65, and News Corp. (NWSA) $18.55 +0.27.

ShowHide Related Items >><<
TSLA Tesla
$113.52 /

+4.47 (+4.10%)

TECH Bio-Techne
$83.22 /

+1.11 (+1.35%)

NWSA News Corp.
$18.33 /

+0.05 (+0.27%)

GNRC Generac
$95.75 /

+4.6 (+5.05%)

DXCM DexCom
$110.63 /

+0.79 (+0.72%)

TSLA Tesla
$113.52 /

+4.47 (+4.10%)

12/28/22 Wedbush
Wedbush lays out what needs to happen for Tesla shares to bottom
12/28/22 Baird
Baird cuts Tesla target to $252, keeps as 'Best Idea' in 2023
12/23/22 Wedbush
Tesla price target lowered to $175 from $250 at Wedbush
12/22/22 Canaccord
Tesla price target lowered to $275 from $304 at Canaccord
GNRC Generac
$95.75 /

+4.6 (+5.05%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
TECH Bio-Techne
$83.22 /

+1.11 (+1.35%)

12/13/22 Deutsche Bank
Bio-Techne initiated with a Buy at Deutsche Bank
12/12/22 Citi
Bio-Techne upgraded to Buy from Neutral at Citi
12/12/22 Citi
Bio-Techne upgraded to Buy from Neutral at Citi
12/06/22 RBC Capital
Bio-Techne initiated with a Sector Perform at RBC Capital
DXCM DexCom
$110.63 /

+0.79 (+0.72%)

12/20/22 Stifel
DexCom price target raised to $130 from $120 at Stifel
12/12/22 Citi
DexCom price target raised to $146 from $117 at Citi
10/28/22 Cowen
DexCom price target raised to $114 from $85 at Cowen
10/28/22 Citi
DexCom price target raised to $117 from $105 at Citi
NWSA News Corp.
$18.33 /

+0.05 (+0.27%)

10/17/22 Morgan Stanley
Morgan Stanley says Fox-News combo would balance more scale with more complexity
10/17/22 Loop Capital
News Corp. downgraded to Hold from Buy at Loop Capital
10/17/22 Credit Suisse
Fox Corp. downgraded to Neutral from Outperform at Credit Suisse
07/28/22 Macquarie
News Corp. downgraded to Neutral at Macquarie ahead of expected 'soft' report
TSLA Tesla
$113.52 /

+4.47 (+4.10%)

TECH Bio-Techne
$83.22 /

+1.11 (+1.35%)

NWSA News Corp.
$18.33 /

+0.05 (+0.27%)

GNRC Generac
$95.75 /

+4.6 (+5.05%)

DXCM DexCom
$110.63 /

+0.79 (+0.72%)

TSLA Tesla
$113.52 /

+4.47 (+4.10%)

NWSA News Corp.
$18.33 /

+0.05 (+0.27%)

GNRC Generac
$95.75 /

+4.6 (+5.05%)

TSLA Tesla
$113.52 /

+4.47 (+4.10%)

NWSA News Corp.
$18.33 /

+0.05 (+0.27%)

GNRC Generac
$95.75 /

+4.6 (+5.05%)

DXCM DexCom
$110.63 /

+0.79 (+0.72%)

TSLA Tesla
$113.52 /

+4.47 (+4.10%)

GNRC Generac
$95.75 /

+4.6 (+5.05%)

DXCM DexCom
$110.63 /

+0.79 (+0.72%)

On The Fly
Fly Intel: Pre-market Movers » 09:17
12/28/22
12/28
09:17
12/28/22
09:17
JNCE

Jounce Therapeutics

/

+

, KALA

Kala Pharmaceuticals

$3.90 /

+0.1 (+2.63%)

, PXLW

Pixelworks

$1.45 /

+0.08 (+5.86%)

, GNRC

Generac

$91.15 /

-1.01 (-1.10%)

, TSLA

Tesla

$109.05 /

-14.09 (-11.44%)

, UTRS

Minerva Surgical

/

+

, LUV

Southwest

$33.94 /

-2.145 (-5.94%)

, GILD

Gilead

$85.00 /

+0.28 (+0.33%)

Check out this morning's…

ShowHide Related Items >><<
UTRS Minerva Surgical
/

+

TSLA Tesla
$109.05 /

-14.09 (-11.44%)

PXLW Pixelworks
$1.45 /

+0.08 (+5.86%)

LUV Southwest
$33.94 /

-2.145 (-5.94%)

KALA Kala Pharmaceuticals
$3.90 /

+0.1 (+2.63%)

JNCE Jounce Therapeutics
/

+

GNRC Generac
$91.15 /

-1.01 (-1.10%)

GILD Gilead
$85.00 /

+0.28 (+0.33%)

JNCE Jounce Therapeutics
/

+

11/11/22 Raymond James
Raymond James downgrades Jounce to Outperform on ILT inhibitor data
11/10/22 Raymond James
Jounce Therapeutics downgraded to Outperform from Strong Buy at Raymond James
08/30/22 Piper Sandler
Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
08/05/22 H.C. Wainwright
Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
KALA Kala Pharmaceuticals
$3.90 /

+0.1 (+2.63%)

11/09/22 Wedbush
Kala Pharmaceuticals price target raised to $47 from $3 at Wedbush
05/24/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
05/17/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $5 from $6 at H.C. Wainwright
03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
PXLW Pixelworks
$1.45 /

+0.08 (+5.86%)

01/18/22 Colliers
Pixelworks upgraded to Buy from Neutral at Colliers
GNRC Generac
$91.15 /

-1.01 (-1.10%)

12/28/22 Northland
Generac named a 'top pick for 2023' at Northland
12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
TSLA Tesla
$109.05 /

-14.09 (-11.44%)

12/28/22 Wedbush
Wedbush lays out what needs to happen for Tesla shares to bottom
12/28/22 Baird
Baird cuts Tesla target to $252, keeps as 'Best Idea' in 2023
12/23/22 Wedbush
Tesla price target lowered to $175 from $250 at Wedbush
12/22/22 Canaccord
Tesla price target lowered to $275 from $304 at Canaccord
UTRS Minerva Surgical
/

+

10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
08/10/22 JPMorgan
Minerva Surgical downgraded to Underweight from Overweight at JPMorgan
08/09/22 Piper Sandler
Minerva Surgical price target lowered to $5 from $6 at Piper Sandler
05/12/22 Piper Sandler
Minerva Surgical price target lowered to $6 from $12 at Piper Sandler
LUV Southwest
$33.94 /

-2.145 (-5.94%)

12/16/22 Goldman Sachs
Southwest resumed with a Neutral at Goldman Sachs
12/15/22 Cowen
Copa Holdings upgraded to Outperform at Cowen amid airlines rating shake-up
12/08/22 Susquehanna
Southwest guidance suggests risk around order book, says Susquehanna
12/08/22 Deutsche Bank
Southwest price target raised to $62 from $60 at Deutsche Bank
GILD Gilead
$85.00 /

+0.28 (+0.33%)

12/22/22 Piper Sandler
Gilead's Sunlenca could expand into broader HIV, says Piper Sandler
12/13/22 BofA
Gilead resumed with a Neutral at BofA
12/12/22 Needham
Arcellx price target raised to $35 from $31 at Needham
12/09/22 Piper Sandler
Gilead price target raised to $104 from $96 at Piper Sandler
UTRS Minerva Surgical
/

+

TSLA Tesla
$109.05 /

-14.09 (-11.44%)

PXLW Pixelworks
$1.45 /

+0.08 (+5.86%)

LUV Southwest
$33.94 /

-2.145 (-5.94%)

KALA Kala Pharmaceuticals
$3.90 /

+0.1 (+2.63%)

JNCE Jounce Therapeutics
/

+

GNRC Generac
$91.15 /

-1.01 (-1.10%)

GILD Gilead
$85.00 /

+0.28 (+0.33%)

TSLA Tesla
$109.05 /

-14.09 (-11.44%)

LUV Southwest
$33.94 /

-2.145 (-5.94%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

TSLA Tesla
$109.05 /

-14.09 (-11.44%)

LUV Southwest
$33.94 /

-2.145 (-5.94%)

KALA Kala Pharmaceuticals
$3.90 /

+0.1 (+2.63%)

JNCE Jounce Therapeutics
/

+

GNRC Generac
$91.15 /

-1.01 (-1.10%)

GILD Gilead
$85.00 /

+0.28 (+0.33%)

TSLA Tesla
$109.05 /

-14.09 (-11.44%)

LUV Southwest
$33.94 /

-2.145 (-5.94%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

GILD Gilead
$85.00 /

+0.28 (+0.33%)

Recommendations
Generac named a 'top pick for 2023' at Northland » 09:10
12/28/22
12/28
09:10
12/28/22
09:10
GNRC

Generac

$91.15 /

-1.01 (-1.10%)

Northland analyst Donovan…

Northland analyst Donovan Schafer selected Generac as a "top pick for 2023," citing his belief that the market is overlooking recent outage events that should drive home standby, or "HSB," generator demand while being "distracted by the near-term installation bottlenecks that obscure the underlying reality" that he expects to become clearer as 2023 unfolds. Hurricane Ian, the 1.5M in outages two days before Christmas, an outage-causing earthquake, and two terror attacks, are all recent events that highlight "grid vulnerability," said Schafer, who keeps an Outperform rating and $180 price target on Generac shares.

ShowHide Related Items >><<
GNRC Generac
$91.15 /

-1.01 (-1.10%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

12/28/22 Janney Montgomery Scott
Janney starts Generac with a Buy, sees core HSB headwinds priced in
12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
12/13/22 Stifel
Generac transferred with a Hold, price target lowered to $98 at Stifel
GNRC Generac
$91.15 /

-1.01 (-1.10%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

Initiation
Janney starts Generac with a Buy, sees core HSB headwinds priced in » 07:47
12/28/22
12/28
07:47
12/28/22
07:47
GNRC

Generac

$91.15 /

-1.01 (-1.10%)

As previously reported,…

As previously reported, Janney Montgomery Scott analyst Sean Milligan initiated coverage of Generac with a Buy rating and $160 fair value estimate. The core residential home standby, or "HSB," generator business is in the early stages of a downturn, but with shares down about 80% from their peak Milligan feels this "has already been discounted in the share price," he tells investors. The shares now trading at a discount to industrial peers presents a "free option" on clean energy growth, argues Milligan, who also sees consistent free cash flow generation and buyback potential providing potential support for the stock and balancing out near-term concerns for residential HSB market trends.

ShowHide Related Items >><<
GNRC Generac
$91.15 /

-1.01 (-1.10%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

12/28/22 Janney Montgomery Scott
Generac initiated with a Buy at Janney Montgomery Scott
12/20/22 Baird
Generac downgraded to Neutral from Outperform at Baird
12/13/22 Stifel
Generac transferred with a Hold, price target lowered to $98 at Stifel
12/08/22 Oppenheimer
Generac price target lowered to $115 from $135 at Oppenheimer
GNRC Generac
$91.15 /

-1.01 (-1.10%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

GNRC Generac
$91.15 /

-1.01 (-1.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.